CUMYL-NBMINACA (SGT-152, Cumyl-BC[2.2.1]HpMINACA) is a synthetic cannabinoid compound first reported in a 2013 patent,[1] but not identified as a designer drug until 2021, being identified by a forensic laboratory in Germany in February 2021.[2][3]
This cannabinoid related article is a stub. You can help Wikipedia by expanding it.
Lokasi Pengunjung: 52.14.89.212